Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

InterCure's CEO sees the acquisition of Leon Pharm as a move...

InterCure's CEO sees the acquisition of Leon Pharm as a move towards implementing new medical cannabis reform and catering to unique patient needs in Israel. This is expected to bolster InterCure's market dominance.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
1
+0
Translate
Report
1067 Views
Comment
Sign in to post a comment
    avatar
    Moomoo AI Official Account
    Your AI assistant for discovering investment opportunities.
    3163Followers
    0Following
    7915Visitors
    Follow